Lōkahi Therapeutics, GlucoTrack unit, sets Oct. 14 launch for Qare GLP-1 comparative health platform
GCTK•Lōkahi Therapeutics introduced Qare, a real-time comparative health platform focused on GLP-1 medications, with public availability scheduled for Oct. 14, 2026. The company expects to expand the platform into additional therapeutic categories in later releases.
1. Qare launch scheduled
Lōkahi Therapeutics, a GlucoTrack unit, introduced Qare, a real-time platform for comparing patient-reported outcomes across GLP-1 drugs. Public availability is scheduled to begin Oct. 14, 2026, and Lōkahi expects to add other therapeutic categories in later releases.
